Shares of Catalyst Pharmaceuticals slid 3.24% to $3.44 at 14:12 EST on Wednesday, following yesterday's upward trend. The Nasdaq Stock Market is dropping 1.38% to $12,409.00, after four sequential sessions in a row of gains, on what up until now seems, an all-around negative trend trading session today.
Catalyst Pharmaceuticals's last close was $3.55, 53.71% under its 52-week high of $5.28.
Catalyst Pharmaceuticals's Sales
Catalyst Pharmaceuticals's sales growth is 11.6% for the present quarter and 4.6% for the next. The company's growth estimates for the current quarter is 25% and a drop 10% for the next.
Catalyst Pharmaceuticals's Revenue
Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.
Catalyst Pharmaceuticals's Stock Top and Bottom Yearly Value
Catalyst Pharmaceuticals's stock is valued at $3.44 at 14:12 EST, way under its 52-week high of $5.28 and way above its 52-week low of $2.55.